| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.830 | 38.410 | 41.316 | 40.384 | 45.685 | 51.057 | 68.708 | 81.747 |
| Total Income - EUR | - | - | 12.830 | 38.410 | 41.316 | 43.485 | 45.888 | 51.058 | 68.708 | 81.747 |
| Total Expenses - EUR | - | - | 10.719 | 30.145 | 37.507 | 45.230 | 40.222 | 39.185 | 41.578 | 46.002 |
| Gross Profit/Loss - EUR | - | - | 2.111 | 8.265 | 3.809 | -1.745 | 5.666 | 11.873 | 27.130 | 35.746 |
| Net Profit/Loss - EUR | - | - | 1.762 | 7.881 | 3.396 | -2.129 | 5.216 | 11.373 | 26.457 | 33.342 |
| Employees | - | - | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Ilimar Hipomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 7.829 | 5.636 | 3.517 | 1.479 | 0 | 0 | 0 | 598 |
| Current Assets | - | - | 4.932 | 12.091 | 11.546 | 9.661 | 11.053 | 14.464 | 30.306 | 38.224 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.290 | 3.060 | 3.414 | 3.387 | 3.535 | 4.386 | 10.388 | 5.022 |
| Cash | - | - | 2.643 | 9.031 | 8.132 | 6.274 | 7.518 | 10.078 | 19.919 | 33.202 |
| Shareholders Funds | - | - | 1.806 | 7.932 | 6.328 | 1.252 | 6.440 | 11.421 | 26.505 | 33.391 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 10.955 | 9.795 | 8.736 | 9.887 | 4.613 | 3.042 | 3.801 | 5.431 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ilimar Hipomed Srl